Search

Your search keyword '"Injections, Subcutaneou"' showing total 55 results

Search Constraints

Start Over You searched for: Descriptor "Injections, Subcutaneou" Remove constraint Descriptor: "Injections, Subcutaneou"
55 results on '"Injections, Subcutaneou"'

Search Results

1. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

2. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

3. Ofatumumab versus Teriflunomide in Multiple Sclerosis

4. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre

5. Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis

6. High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study

7. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration

8. Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria

9. Dupilumab and alopecia: A Janus effect

10. Vedolizumab versus Adalimumab for moderate-to-severe ulcerative colitis

11. Research Techniques Made Simple: Skin Carcinogenesis Models: Xenotransplantation Techniques

12. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

13. Skin complications of insulin injections: A case presentation and a possible explanation of hypoglycaemia

14. Subcutaneous interferon ß-1a in the treatment of clinically isolated syndromes:3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study

15. Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies

16. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

17. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

18. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis

19. Therapeutic use of hyaluronic acid fillers in the treatment of corticosteroid-induced skin and subcutaneous atrophy

20. Skin Necrosis Following Adipocitolitic Solution Injections

21. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

22. Early introduction of subcutaneous hepatitis B immunoglobulin following liver transplantation for hepatitis B virus infection: A prospective, multicenter study

23. A CE-marked drug used for localized adiposity reduction: A 4-year experience

24. Dynamic behavior of a spring-powered micronozzle needle-free injector

25. How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis

26. Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study

27. Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series

28. Refractory rheumatoid factor positive polyarthritis in a female adolescent already suffering from type 1 diabetes mellitus and Hashimoto's thyroiditis successfully treated with etanercept

29. Occurrence and extent of bruising according to duration of administration of subcutaneous Low-Molecular-Weight Heparin: a quasi-experimental case-crossover study

30. Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia

31. New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation

32. Effects of lanreotide autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: A 1-year prospective multicenter study

33. Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia

34. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia

35. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease

36. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients

38. Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy

39. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action

40. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia

41. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study

42. Clinical role of interleukin-2 in the surgical treatment of liver metastasis due to colon adenocarcinoma

43. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients

44. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action

45. New active series of growth hormone secretagogues

46. Lymphocyte counts independently predict overall survival in advanced cancer patients: a biomarker for IL-2 immunotherapy

47. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa

48. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic study

49. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa

50. Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat

Catalog

Books, media, physical & digital resources